AbCellera

AbCellera: Series B Funding Round

AbCellera has successfully raised $555M in Series B funding, reaching a valuation of $5.7B.

Company Overview

Antibody discovery platform

Funding Details

The Series B round was led by Peter Thiel, with participation from Eli Lilly, Fast Forward Innovations, DCVC Bio.

Company Information

• Headquarters: 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
• Founded: 2012
• Employees: 400+
• Category: Biotech

Investment

AbCellera plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• Peter Thiel: Verified investor in Series B
• Eli Lilly: Verified investor in Series B
• Fast Forward Innovations: Verified investor in Series B
• DCVC Bio: Verified investor in Series B